세계의 통증 완화 패치 시장 : 분석, 규모, 점유율, 성장, 동향, 예측(2024-2033년)

Pain Relief Patches Market: Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2024-2033

US $ 4,995 ￦ 7,088,000

Unprintable PDF & Excel (Single User License)

PDF, Excel 보고서를 1명만 이용할 수 있는 라이선스입니다. 텍스트의 복사, 인쇄가 불가능합니다.

US $ 7,295 ￦ 10,352,000

PDF & Excel (Multi User License)

PDF, Excel 보고서를 동일 기업 내 5명까지 이용할 수 있는 라이선스입니다. 텍스트의 Copy&Paste와 인쇄가 가능합니다.

US $ 8,495 ￦ 12,055,000

PDF & Excel (Corporate User License)

PDF, Excel 보고서를 동일 기업의 모든 분이 이용할 수 있는 라이선스입니다. 텍스트의 Copy&Paste와 인쇄가 가능합니다.

한글목차

Persistence Market Research는 최근 통증 완화 패치 시장에 대한 종합적인 보고서를 발표했습니다. 이 보고서는 시장 성장 촉진요인, 동향, 기회 및 과제를 포함한 중요한 시장 역학을 철저히 평가하고 시장 구조에 대한 자세한 통찰력을 제공합니다.

주요 인사이트 : 통증 완화 패치 시장

• 시장 규모(2024년) : 12억 달러
• 예측 시장 가치(2033년) : 19억 달러
• 복합 연간 성장률(CAGR) 2024년-2033년) : 5.2%

통증 완화 패치 시장 : 조사 범위 :

통증 완화 패치는 다양한 유형의 통증 치료에 중요한 역할을 하며, 유효한 약제 성분(API)의 경피 투여에 의한 국소 완화를 제공합니다. 이러한 패치는 경구 약물 및 침습 치료를 대체하기 위해 임상 현장, 재택 관리 환경, 스포츠 의료 등에서 널리 사용됩니다. 이 시장은 근골격계의 통증, 관절염, 수술 후 통증 관리 등 다양한 통증 증상에 대응하고 있습니다.

시장 성장 촉진요인:

세계 통증 완화 패치 시장은 관절염과 요통과 같은 만성 통증 증상의 유병률 증가와 같은 몇 가지 중요한 요인에 의해 견인되고 있습니다. 비침습적인 통증 관리 솔루션으로의 이동과 국소 약물 전달 방법에 대한 선호도가 시장 확대에 크게 기여하고 있습니다. 점착성 향상 및 약물 방출 연장과 같은 패치 디자인의 기술적 진보는 환자의 편안함과 치료 효과를 높이고 시장 성장을 더욱 자극하고 있습니다.

시장 성장 억제요인:

유망한 성장 전망에도 불구하고, 통증 완화 패치 시장은 규제 당국의 승인, 특히 패치를 의료기기 또는 의약품으로 분류하는 문제에 직면하고 있습니다. 또한 지역에 따라 상환 정책이 다르거나 특정 패치 제제와 관련된 피부 자극과 알레르기 반응에 대한 우려도 시장 침투를 방해하고 있습니다.

시장 기회:

통증 완화 패치 시장은 패치 기술의 진보와 비 오피오이드 계통통 관리 옵션에 대한 소비자 의식 증가로 인해 큰 성장 기회를 제공합니다. 혁신적인 제제를 개발하고 시장 진입을 확대하기 위한 제약 기업과 패치 제조업체의 전략적 제휴는 새로운 기회를 활용할 것으로 기대됩니다. 또한 원격 의료 및 전자상거래 플랫폼에 의한 통증 완화 패치의 유통이 확대됨에 따라 다양한 환자층이 이러한 제품에 접근할 수 있게 되었습니다.

이 보고서에서 다루는 주요 질문

• 통증 완화 패치 시장의 세계 성장을 가속하는 주요 요인은 무엇인가?
• 통증 완화 패치의 채용을 촉진하는 통증 상태와 환자층은 무엇인가?
• 기술 진보는 통증 완화 패치 시장 경쟁 구도를 어떻게 바꾸고 있는가?
• 통증 완화 패치 시장에 기여하는 주요 기업은 어딘가, 시장 관련성을 유지하기 위해 어떤 전략을 채택하고 있는가?
• 세계 통증 완화 패치 시장의 새로운 동향과 장래 전망은?

목차

제1장 주요 요약

제2장 시장 개요

• 시장 범위/분류
• 시장의 정의/범위/제한
• 포함과 제외

제3장 주요 시장 동향

• 시장에 영향을 주는 주요 동향
• 혁신/개발 동향

제4장 중요한 성공 요인

• 주요 기업별 주요 프로모션 전략
• 제품의 채용/사용 상황 분석
• 기술평가
• 규제 시나리오
• 밸류체인 분석
• Porter's Five Forces 분석
• PESTEL 분석

제5장 시장 배경

• 거시경제 요인
• 예측 요인- 관련성과 영향
• 시장 역학

제6장 COVID-19 위기 분석

• COVID-19와 영향 분석
  • 제품별
  • 적응증별
  • 유통 채널별
  • 지역별
• 2024년 시장 시나리오

제7장 시장의 가격 분석

• 지역별 가격 분석(제품 유형별)
• 세계 평균 가격 분석 벤치마크
• 가격 설정의 전제

제8장 시장 수요(금액) 분석

• 과거 시장 규모(금액) 분석(2019년-2023년)
• 현재 및 장래 시장 규모(금액) 분석과 예측(2024년-2033년)
  • 전년대비 성장 분석
  • 절대적 수익 기회 분석

제9장 시장 분석, 제품별

• 소개/주요 조사 결과
• 과거 시장 규모(금액) 분석(2019년-2023년)
• 현재 및 장래 시장 규모(금액)의 분석과 예측, 제품별(2024년-2033년)
  • 비스테로이드성 항염증제 패치
  • 케트로프로펜 패치
  • 디클로페낙 패치
  • 풀루비프로펜 패치
  • 피록시 캠 패치
  • 오피오이드 패치
  • 펜타닐 패치
  • 부프레노르핀
  • 국소 마취 패치
  • 니트로글리세린 패치
  • 캡사이신 패치
  • 리도카인 패치
• 제품별 시장의 매력 분석

제10장 시장 분석, 지표별

• 소개/주요 조사 결과
• 과거 시장 규모(금액) 분석(2019년-2023년)
• 현재 및 장래 시장 규모(금액)의 분석과 예측, 적응증별(2024년-2033년)
  • 월경통
  • 정형외과적 통증
  • 신경장애성 통증
  • 수술 후 통증
  • 심장혈관의 통증
  • 기타
• 증상별 시장의 매력 분석

제11장 시장 분석, 유통 채널별

• 소개/주요 조사 결과
• 과거 시장 규모(금액) 분석(2019년-2023년)
• 현재 및 장래 시장 규모(금액)의 분석과 예측, 유통 채널별(2024년-2033년)
  • 병원 약국
  • 소매 약국
  • 온라인 약국
• 유통 채널별 시장의 매력 분석

제12장 시장 분석, 지역별

• 소개
• 과거 시장 규모(금액) 분석, 지역별(2019년-2023년)
• 현재 및 장래 시장 규모(금액)의 분석과 예측, 지역별(2024년-2033년)
  • 북미
  • 라틴아메리카
  • 유럽
  • 동아시아
  • 남아시아
  • 오세아니아
  • 중동 및 아프리카(중동 및 아프리카)
• 지역별 시장의 매력 분석

제13장 북미 시장 분석

제14장 라틴아메리카 시장 분석

제15장 유럽 시장 분석

제16장 남부 시장 분석

• 소개
• 과거 시장 규모(금액) 분석, 분류별(2019년-2023년)
• 현재 및 장래 시장 규모(금액)의 분석과 예측, 분류별(2024년-2033년)
  • 국가별
    • 인도
    • 태국
    • 인도네시아
    • 말레이시아
    • 기타 남아시아
  • 제품별
  • 적응증별
  • 유통 채널별
• 시장의 매력 분석
• 시장 동향
• 주요 시장 진출기업 - 강도 매핑
• 성장 촉진요인과 제약- 영향 분석
• 국가 수준의 분석과 예측

제17장 동부 시장 분석

• 소개
• 과거 시장 규모(금액) 분석, 분류별(2019년-2023년)
• 현재 및 장래 시장 규모(금액)의 분석과 예측, 분류별(2024년-2033년)
  • 국가별
    • 중국
    • 일본
    • 한국
  • 제품별
  • 적응증별
  • 유통 채널별
• 시장의 매력 분석
• 시장 동향
• 주요 시장 진출기업 - 강도 매핑
• 성장 촉진요인과 제약 - 영향 분석
• 국가 수준의 분석과 예측

제18장 오세아니아 시장 분석

제19장 중동 및 아프리카(MEA) 시장 분석

제20장 시장 구조 분석

• 기업 Tier별 시장 분석
• 주요 기업의 시장 점유율 분석
• 기술의 발자국

제21장 경쟁 분석

• 경쟁 대시보드
• 경쟁 벤치마킹
• 경쟁의 상세
  • Viatris, Inc.(Mylan)
  • Obalon Therapeutics, Inc.
  • Johnson &Johnson Services, Inc.
  • Teva Pharmaceutical Industries Ltd.
  • Sanofi SA
  • Hisamitsu Pharmaceutical Co., Inc.
  • GlaxoSmithKline Plc.
  • Novartis AG
  • Nichiban Co., Ltd.
  • Teikoku Seiyaku Co, Ltd.
  • Mentholatum Company.
  • Purdue Pharma LP
  • West-Ward Pharmaceuticals Corporation
  • Pfizer, Inc
  • Allergan Plc(Actavis)
  • Endo International plc,
  • Mylan NV

제22장 사용된 전제조건과 약어

제23장 조사 방법

BJH

영문 목차

영문목차

Persistence Market Research has recently released a comprehensive report on the worldwide market for pain relief patches. The report offers a thorough assessment of crucial market dynamics, including drivers, trends, opportunities, and challenges, providing detailed insights into the market structure.

Key Insights: Pain Relief Patches Market

• Market Size (2024E): USD 1.2 Billion
• Projected Market Value (2033F): USD 1.9 Billion
• Global Market Growth Rate (CAGR 2024 to 2033): 5.2%

Pain Relief Patches Market - Report Scope:

Pain relief patches play a crucial role in the treatment of various types of pain, offering localized relief through transdermal delivery of active pharmaceutical ingredients (APIs). These patches are used widely in clinical settings, homecare environments, and sports medicine, providing alternatives to oral medications and invasive treatments. The market caters to a diverse range of pain conditions, including musculoskeletal pain, arthritis, and post-operative pain management.

Market Growth Drivers:

The global pain relief patches market is driven by several key factors, including increasing prevalence of chronic pain conditions such as arthritis and lower back pain. The shift towards non-invasive pain management solutions and the preference for localized drug delivery methods contribute significantly to market expansion. Technological advancements in patch design, such as improved adhesion and prolonged drug release capabilities, enhance patient comfort and treatment efficacy, further stimulating market growth.

Market Restraints:

Despite promising growth prospects, the pain relief patches market faces challenges related to regulatory approvals, particularly concerning the classification of patches as medical devices or pharmaceutical products. Variations in reimbursement policies across different regions and concerns regarding skin irritation and allergic reactions associated with certain patch formulations also hinder market penetration.

Market Opportunities:

The pain relief patches market presents significant growth opportunities driven by advancements in patch technology and increasing consumer awareness about non-opioid pain management options. Strategic collaborations between pharmaceutical companies and patch manufacturers to develop innovative formulations and expand market reach are expected to capitalize on emerging opportunities. Moreover, the growing adoption of telemedicine and e-commerce platforms for the distribution of pain relief patches broadens access to these products across diverse patient demographics.

Key Questions Answered in the Report:

• What are the primary factors driving the growth of the pain relief patches market globally?
• Which pain conditions and patient demographics are driving adoption of pain relief patches?
• How are technological advancements reshaping the competitive landscape of the pain relief patches market?
• Who are the key players contributing to the pain relief patches market, and what strategies are they employing to maintain market relevance?
• What are the emerging trends and future prospects in the global pain relief patches market?

Competitive Intelligence and Business Strategy:

Leading players in the global pain relief patches market, including [Company A], [Company B], and [Company C], focus on innovation, product differentiation, and strategic partnerships to gain a competitive edge. These companies invest in R&D to develop advanced patch formulations, enhance drug delivery capabilities, and improve patient compliance. Collaborations with healthcare providers and retail distributors facilitate market expansion, while investments in clinical research and regulatory compliance ensure product safety and efficacy.

Key Companies Profiled:

• Viatris, Inc. (Mylan)
• Johnson & Johnson Services, Inc.
• Teva Pharmaceutical Industries Ltd.
• Sanofi S.A.
• Hisamitsu Pharmaceutical Co., Inc.
• GlaxoSmithKline Plc.
• Novartis AG
• Nichiban Co., Ltd.
• Teikoku Seiyaku Co, Ltd.
• Mentholatum Company
• Purdue Pharma L.P.
• West-Ward Pharmaceuticals Corporation
• Pfizer, Inc
• Allergan PLC (Actavis)
• Endo International PLC
• Mylan N.V.
• Corium, Inc.
• Agile Therapeutics Inc.

Pain Relief Patches Industry Research Segmentation

By Product Type:

• Non-steroidal Anti-inflammatory Drug Patches
• Opioid Patches
• Local Anesthetic Patches

By Indication:

• Menstrual Cramps
• Orthopedic Pain
• Neuropathic Pain
• Post-operative Pain
• Cardiovascular Pain
• Others

By Distribution Channel:

• Hospital Pharmacies
• Retail Pharmacies
• Online Pharmacies

By Region:

• North America
• Latin America
• Europe
• South Asia
• East Asia
• Oceania
• Middle East and Africa (MEA)

Table of Contents

1. Executive Summary

• 1.1. Global Market Outlook
• 1.2. Demand Side Trends
• 1.3. Supply Side Trends
• 1.4. Analysis and Recommendations

2. Market Overview

• 2.1. Market Coverage / Taxonomy
• 2.2. Market Definition / Scope / Limitations
• 2.3. Inclusions & Exclusions

3. Key Market Trends

• 3.1. Key Trends Impacting the Market
• 3.2. Innovation / Development Trends

4. Key Success Factors

• 4.1. Key Promotional Strategies, By Key Player
• 4.2. Product Adoption/Usage Analysis
• 4.3. Technology Assessment
• 4.4. Regulatory Scenario
• 4.5. Value Chain Analysis
• 4.6. Porter's Analysis
• 4.7. PESTEL analysis

5. Market Background

• 5.1. Macro-Economic Factors
  • 5.1.1. Global GDP Growth Outlook
  • 5.1.2. Global Healthcare Market Outlook
  • 5.1.3. Per Capita Healthcare Spending Outlook
• 5.2. Forecast Factors - Relevance & Impact
  • 5.2.1. Top Companies Historical Growth
  • 5.2.2. Product Adoption Rate and Demand
  • 5.2.3. New Product Launches
  • 5.2.4. Increase in Demand for Non-invasive Pain Management Treatment
  • 5.2.5. Changing Regulatory Dynamics
• 5.3. Market Dynamics
  • 5.3.1. Drivers
  • 5.3.2. Restraints
  • 5.3.3. Opportunity Analysis

6. COVID-19 Crisis Analysis

• 6.1. COVID-19 and Impact Analysis
  • 6.1.1. By Product
  • 6.1.2. By Indication
  • 6.1.3. By Distribution Channel
  • 6.1.4. By Region
• 6.2. 2024 Market Scenario

7. Global Market Pricing Analysis

• 7.1. Regional Pricing Analysis, By Product Type
• 7.2. Global Average Pricing Analysis Benchmark
• 7.3. Pricing Assumptions

8. Global Market Value US$ Mn Analysis 2019-2023 and Forecast, 2024-2033

• 8.1. Historical Market Value (US$ Bn) Analysis, 2019-2023
• 8.2. Current and Future Market Value (US$ Bn) Analysis and Forecast, 2024-2033
  • 8.2.1. Y-o-Y Growth Analysis
  • 8.2.2. Absolute $ Opportunity Analysis

9. Global Market Analysis 2019-2023 and Forecast 2024-2033, By Product

• 9.1. Introduction / Key Findings
• 9.2. Historical Market Size (US$ Bn) Analysis, 2019-2023
• 9.3. Current and Future Market Size (US$ Bn) Analysis and Forecast By Product, 2024-2033
  • 9.3.1. Non-Steroidal Anti- Inflammatory Drug Patches
  • 9.3.2. Ketroprofen Patches
  • 9.3.3. Diclofenac Patches
  • 9.3.4. Flurbiprofen Patches
  • 9.3.5. Piroxicam Patches
  • 9.3.6. Opioid Patches
  • 9.3.7. Fentanyl Patches
  • 9.3.8. Buprenorphine
  • 9.3.9. Local Anaesthetic Patches
  • 9.3.10. Nitro-glycerin Patches
  • 9.3.11. Capsaicin Patches
  • 9.3.12. Lidocaine Patches
• 9.4. Market Attractiveness Analysis By Product

10. Global Market Analysis 2019-2023 and Forecast 2024-2033, By Indication

• 10.1. Introduction / Key Findings
• 10.2. Historical Market Size (US$ Bn) Analysis, 2019-2023
• 10.3. Current and Future Market Size (US$ Bn) Analysis and Forecast By Indication, 2024-2033
  • 10.3.1. Menstrual Cramps
  • 10.3.2. Orthopedic Pain
  • 10.3.3. Neuropathic Pain
  • 10.3.4. Post-Operative Pain
  • 10.3.5. Cardiovascular Pain
  • 10.3.6. Others
• 10.4. Market Attractiveness Analysis By Indication

11. Global Market analysis 2019-2023 and forecast 2024-2033, By Distribution Channel

• 11.1. Introduction / Key Findings
• 11.2. Historical Market Size (US$ Bn) Analysis, 2019-2023
• 11.3. Current and Future Market Size (US$ Bn) Analysis and Forecast By Distribution Channel, 2024-2033
  • 11.3.1. Hospital Pharmacies
  • 11.3.2. Retail Pharmacies
  • 11.3.3. Online Pharmacies
• 11.4. Market Attractiveness Analysis By Distribution Channel

12. Global Market Analysis 2019-2023 and Forecast 2024-2033, By Region

• 12.1. Introduction
• 12.2. Historical Market Size (US$ Bn) Analysis, 2019-2023
• 12.3. Current and Future Market Size (US$ Bn) Analysis and Forecast By Region, 2024-2033
  • 12.3.1. North America
  • 12.3.2. Latin America
  • 12.3.3. Europe
  • 12.3.4. East Asia
  • 12.3.5. South Asia
  • 12.3.6. Oceania
  • 12.3.7. Middle East and Africa (MEA)
• 12.4. Market Attractiveness Analysis By Region

13. North America Market Analysis 2019-2023 and Forecast 2024-2033

• 13.1. Introduction
• 13.2. Historical Market Size (US$ Bn) Analysis by Market Taxonomy, 2019-2023
• 13.3. Current and Future Market Size (US$ Bn) Analysis and Forecast by Market Taxonomy, 2024-2033
  • 13.3.1. By Country
    • 13.3.1.1. U.S.
    • 13.3.1.2. Canada
  • 13.3.2. By Product
  • 13.3.3. By Indication
  • 13.3.4. By Distribution Channel
• 13.4. Market Attractiveness Analysis
  • 13.4.1. By Country
  • 13.4.2. By Product
  • 13.4.3. By Indication
  • 13.4.4. By Distribution Channel
• 13.5. Market Trends
• 13.6. Key Market Participants - Intensity Mapping
• 13.7. Drivers and Restraints - Impact Analysis
• 13.8. Country Level Analysis & Forecast
  • 13.8.1. U.S. Market
    • 13.8.1.1. Introduction
    • 13.8.1.2. Market Analysis and Forecast by Market Taxonomy
      • 13.8.1.2.1. By Product
      • 13.8.1.2.2. By Indication
      • 13.8.1.2.3. By Distribution Channel
  • 13.8.2. Canada Market
    • 13.8.2.1. Introduction
    • 13.8.2.2. Market Analysis and Forecast by Market Taxonomy
      • 13.8.2.2.1. By Product
      • 13.8.2.2.2. By Indication
      • 13.8.2.2.3. By Distribution Channel

14. Latin America Market Analysis 2019-2023 and Forecast 2024-2033

• 14.1. Introduction
• 14.2. Historical Market Size (US$ Bn) Analysis By Market Taxonomy, 2019-2023
• 14.3. Current and Future Market Size (US$ Bn) Analysis and Forecast By Market Taxonomy, 2024-2033
  • 14.3.1. By Country
    • 14.3.1.1. Brazil
    • 14.3.1.2. Mexico
    • 14.3.1.3. Rest of Latin America
  • 14.3.2. By Product
  • 14.3.3. By Indication
  • 14.3.4. By Distribution Channel
• 14.4. Market Attractiveness Analysis
  • 14.4.1. By Country
  • 14.4.2. By Product
  • 14.4.3. By Indication
  • 14.4.4. By Distribution Channel
• 14.5. Market Trends
• 14.6. Key Market Participants - Intensity Mapping
• 14.7. Drivers and Restraints - Impact Analysis
• 14.8. Country Level Analysis & Forecast
  • 14.8.1. Brazil Market
    • 14.8.1.1. Introduction
    • 14.8.1.2. Market Analysis and Forecast by Market Taxonomy
      • 14.8.1.2.1. By Product
      • 14.8.1.2.2. By Indication
      • 14.8.1.2.3. By Distribution Channel
  • 14.8.2. Argentina Market
    • 14.8.2.1. Introduction
    • 14.8.2.2. Market Analysis and Forecast by Market Taxonomy
      • 14.8.2.2.1. By Product
      • 14.8.2.2.2. By Indication
      • 14.8.2.2.3. By Distribution Channel
  • 14.8.3. Mexico Market
    • 14.8.3.1. Introduction
    • 14.8.3.2. Market Analysis and Forecast by Market Taxonomy
      • 14.8.3.2.1. By Product
      • 14.8.3.2.2. By Indication
      • 14.8.3.2.3. By Distribution Channel

15. Europe Market Analysis 2019-2023 and Forecast 2024-2033

• 15.1. Introduction
• 15.2. Historical Market Size (US$ Bn) Analysis By Market Taxonomy, 2019-2023
• 15.3. Current and Future Market Size (US$ Bn) Analysis and Forecast By Market Taxonomy, 2024-2033
  • 15.3.1. By Country
    • 15.3.1.1. Germany
    • 15.3.1.2. Italy
    • 15.3.1.3. France
    • 15.3.1.4. U.K.
    • 15.3.1.5. Spain
    • 15.3.1.6. BENELUX
    • 15.3.1.7. Russia
    • 15.3.1.8. Rest of Europe
  • 15.3.2. By Product
  • 15.3.3. By Indication
  • 15.3.4. By Distribution Channel
• 15.4. Market Attractiveness Analysis
  • 15.4.1. By Country
  • 15.4.2. By Product
  • 15.4.3. By Indication
  • 15.4.4. By Distribution Channel
• 15.5. Market Trends
• 15.6. Key Market Participants - Intensity Mapping
• 15.7. Drivers and Restraints - Impact Analysis
• 15.8. Country Level Analysis & Forecast
  • 15.8.1. Germany Market
    • 15.8.1.1. Introduction
    • 15.8.1.2. Market Analysis and Forecast by Market Taxonomy
      • 15.8.1.2.1. By Product
      • 15.8.1.2.2. By Indication
      • 15.8.1.2.3. By Distribution Channel
  • 15.8.2. France Market
    • 15.8.2.1. Introduction
    • 15.8.2.2. Market Analysis and Forecast by Market Taxonomy
      • 15.8.2.2.1. By Product
      • 15.8.2.2.2. By Indication
      • 15.8.2.2.3. By Distribution Channel
  • 15.8.3. Italy Market
    • 15.8.3.1. Introduction
    • 15.8.3.2. Market Analysis and Forecast by Market Taxonomy
      • 15.8.3.2.1. By Product
      • 15.8.3.2.2. By Indication
      • 15.8.3.2.3. By Distribution Channel
  • 15.8.4. Spain Market
    • 15.8.4.1. Introduction
    • 15.8.4.2. Market Analysis and Forecast by Market Taxonomy
      • 15.8.4.2.1. By Product
      • 15.8.4.2.2. By Indication
      • 15.8.4.2.3. By Distribution Channel
  • 15.8.5. U.K. Market
    • 15.8.5.1. Introduction
    • 15.8.5.2. Market Analysis and Forecast by Market Taxonomy
      • 15.8.5.2.1. By Product
      • 15.8.5.2.2. By Indication
      • 15.8.5.2.3. By Distribution Channel
  • 15.8.6. Benelux Union Market
    • 15.8.6.1. Introduction
    • 15.8.6.2. Market Analysis and Forecast by Market Taxonomy
      • 15.8.6.2.1. By Product
      • 15.8.6.2.2. By Indication
      • 15.8.6.2.3. By Distribution Channel
  • 15.8.7. Russia Market
    • 15.8.7.1. Introduction
    • 15.8.7.2. Market Analysis and Forecast by Market Taxonomy
      • 15.8.7.2.1. By Product
      • 15.8.7.2.2. By Indication
      • 15.8.7.2.3. By Distribution Channel

16. South Market Analysis 2019-2023 and Forecast 2024-2033

• 16.1. Introduction
• 16.2. Historical Market Size (US$ Bn) Analysis By Market Taxonomy, 2019-2023
• 16.3. Current and Future Market Size (US$ Bn) Analysis and Forecast By Market Taxonomy, 2024-2033
  • 16.3.1. By Country
    • 16.3.1.1. India
    • 16.3.1.2. Thailand
    • 16.3.1.3. Indonesia
    • 16.3.1.4. Malaysia
    • 16.3.1.5. Rest of South Asia
  • 16.3.2. By Product
  • 16.3.3. By Indication
  • 16.3.4. By Distribution Channel
• 16.4. Market Attractiveness Analysis
  • 16.4.1. By Country
  • 16.4.2. By Product
  • 16.4.3. By Indication
  • 16.4.4. By Distribution Channel
• 16.5. Market Trends
• 16.6. Key Market Participants - Intensity Mapping
• 16.7. Drivers and Restraints - Impact Analysis
• 16.8. Country Level Analysis & Forecast
  • 16.8.1. India Market
    • 16.8.1.1. Introduction
    • 16.8.1.2. Market Analysis and Forecast by Market Taxonomy
      • 16.8.1.2.1. By Product
      • 16.8.1.2.2. By Indication
      • 16.8.1.2.3. By Distribution Channel
  • 16.8.2. Indonesia Market
    • 16.8.2.1. Introduction
    • 16.8.2.2. Market Analysis and Forecast by Market Taxonomy
      • 16.8.2.2.1. By Product
      • 16.8.2.2.2. By Indication
      • 16.8.2.2.3. By Distribution Channel
  • 16.8.3. Thailand Market
    • 16.8.3.1. Introduction
    • 16.8.3.2. Market Analysis and Forecast by Market Taxonomy
      • 16.8.3.2.1. By Product
      • 16.8.3.2.2. By Indication
      • 16.8.3.2.3. By Distribution Channel
  • 16.8.4. Malaysia Market
    • 16.8.4.1. Introduction
    • 16.8.4.2. Market Analysis and Forecast by Market Taxonomy
      • 16.8.4.2.1. By Product
      • 16.8.4.2.2. By Indication
      • 16.8.4.2.3. By Distribution Channel

17. East Market Analysis 2019-2023 and Forecast 2024-2033

• 17.1. Introduction
• 17.2. Historical Market Size (US$ Bn) Analysis By Market Taxonomy, 2019-2023
• 17.3. Current and Future Market Size (US$ Bn) Analysis and Forecast By Market Taxonomy, 2024-2033
  • 17.3.1. By Country
    • 17.3.1.1. China
    • 17.3.1.2. Japan
    • 17.3.1.3. South Korea
  • 17.3.2. By Product
  • 17.3.3. By Indication
  • 17.3.4. By Distribution Channel
• 17.4. Market Attractiveness Analysis
  • 17.4.1. By Country
  • 17.4.2. By Product
  • 17.4.3. By Indication
  • 17.4.4. By Distribution Channel
• 17.5. Market Trends
• 17.6. Key Market Participants - Intensity Mapping
• 17.7. Drivers and Restraints - Impact Analysis
• 17.8. Country Level Analysis & Forecast
  • 17.8.1. China Market
    • 17.8.1.1. Introduction
    • 17.8.1.2. Market Analysis and Forecast by Market Taxonomy
      • 17.8.1.2.1. By Product
      • 17.8.1.2.2. By Indication
      • 17.8.1.2.3. By Distribution Channel
  • 17.8.2. Japan Market
    • 17.8.2.1. Introduction
    • 17.8.2.2. Market Analysis and Forecast by Market Taxonomy
      • 17.8.2.2.1. By Product
      • 17.8.2.2.2. By Indication
      • 17.8.2.2.3. By Distribution Channel
  • 17.8.3. South Korea Market
    • 17.8.3.1. Introduction
    • 17.8.3.2. Market Analysis and Forecast by Market Taxonomy
      • 17.8.3.2.1. By Product
      • 17.8.3.2.2. By Indication
      • 17.8.3.2.3. By Distribution Channel

18. Oceania Market Analysis 2019-2023 and Forecast 2024-2033

• 18.1. Introduction
• 18.2. Historical Market Size (US$ Bn) Analysis By Market Taxonomy, 2019-2023
• 18.3. Current and Future Market Size (US$ Bn) Analysis and Forecast By Market Taxonomy, 2024-2033
  • 18.3.1. By Country
    • 18.3.1.1. Australia
    • 18.3.1.2. New Zealand
  • 18.3.2. By Product
  • 18.3.3. By Indication
  • 18.3.4. By Distribution Channel
• 18.4. Market Attractiveness Analysis
  • 18.4.1. By Country
  • 18.4.2. By Product
  • 18.4.3. By Indication
  • 18.4.4. By Distribution Channel
• 18.5. Market Trends
• 18.6. Key Market Participants - Intensity Mapping
• 18.7. Drivers and Restraints - Impact Analysis
• 18.8. Country Level Analysis & Forecast
  • 18.8.1. Australia Market
    • 18.8.1.1. Introduction
    • 18.8.1.2. Market Analysis and Forecast by Market Taxonomy
      • 18.8.1.2.1. By Product
      • 18.8.1.2.2. By Indication
      • 18.8.1.2.3. By Distribution Channel
  • 18.8.2. New Zealand Market
    • 18.8.2.1. Introduction
    • 18.8.2.2. Market Analysis and Forecast by Market Taxonomy
      • 18.8.2.2.1. By Product
      • 18.8.2.2.2. By Indication
      • 18.8.2.2.3. By Distribution Channel

19. Middle East and Africa (MEA) Market Analysis 2019-2023 and Forecast 2024-2033

• 19.1. Introduction
• 19.2. Historical Market Size (US$ Bn) Analysis By Market Taxonomy, 2019-2023
• 19.3. Current and Future Market Size (US$ Bn)Analysis and Forecast By Market Taxonomy, 2024-2033
  • 19.3.1. By Country
    • 19.3.1.1. GCC Countries
    • 19.3.1.2. Turkiye
    • 19.3.1.3. North Africa
    • 19.3.1.4. South Africa
    • 19.3.1.5. Rest of Middle East and Africa
  • 19.3.2. By Product
  • 19.3.3. By Indication
  • 19.3.4. By Distribution Channel
• 19.4. Market Attractiveness Analysis
  • 19.4.1. By Country
  • 19.4.2. By Product
  • 19.4.3. By Indication
  • 19.4.4. By Distribution Channel
• 19.5. Market Trends
• 19.6. Key Market Participants - Intensity Mapping
• 19.7. Drivers and Restraints - Impact Analysis
• 19.8. Country Level Analysis & Forecast
  • 19.8.1. GCC Countries Market
    • 19.8.1.1. Introduction
    • 19.8.1.2. Market Analysis and Forecast by Market Taxonomy
      • 19.8.1.2.1. By Product
      • 19.8.1.2.2. By Indication
      • 19.8.1.2.3. By Distribution Channel
  • 19.8.2. Turkiye Market
    • 19.8.2.1. Introduction
    • 19.8.2.2. Market Analysis and Forecast by Market Taxonomy
      • 19.8.2.2.1. By Product
      • 19.8.2.2.2. By Indication
      • 19.8.2.2.3. By Distribution Channel
  • 19.8.3. South Africa Market
    • 19.8.3.1. Introduction
    • 19.8.3.2. Market Analysis and Forecast by Market Taxonomy
      • 19.8.3.2.1. By Product
      • 19.8.3.2.2. By Indication
      • 19.8.3.2.3. By Distribution Channel
  • 19.8.4. North Africa Market
    • 19.8.4.1. Introduction
    • 19.8.4.2. Market Analysis and Forecast by Market Taxonomy
      • 19.8.4.2.1. By Product
      • 19.8.4.2.2. By Indication
      • 19.8.4.2.3. By Distribution Channel

20. Market Structure Analysis

• 20.1. Market Analysis by Tier of Companies
• 20.2. Market Share Analysis of Top Players
• 20.3. Technology Footprint

21. Competition Analysis

• 21.1. Competition Dashboard
• 21.2. Competition Benchmarking
• 21.3. Competition Deep Dive
  • 21.3.1. Viatris, Inc. (Mylan)
    • 21.3.1.1. Overview
    • 21.3.1.2. Product Portfolio
    • 21.3.1.3. Key Financials
    • 21.3.1.4. SWOT Analysis
    • 21.3.1.5. Sales Footprint
    • 21.3.1.6. Key Developments
    • 21.3.1.7. Strategy Overview
  • 21.3.2. Obalon Therapeutics, Inc.
    • 21.3.2.1. Overview
    • 21.3.2.2. Product Portfolio
    • 21.3.2.3. Key Financials
    • 21.3.2.4. SWOT Analysis
    • 21.3.2.5. Sales Footprint
    • 21.3.2.6. Key Developments
    • 21.3.2.7. Strategy Overview
  • 21.3.3. Johnson & Johnson Services, Inc.
    • 21.3.3.1. Overview
    • 21.3.3.2. Product Portfolio
    • 21.3.3.3. Key Financials
    • 21.3.3.4. SWOT Analysis
    • 21.3.3.5. Sales Footprint
    • 21.3.3.6. Key Developments
    • 21.3.3.7. Strategy Overview
  • 21.3.4. Teva Pharmaceutical Industries Ltd.
    • 21.3.4.1. Overview
    • 21.3.4.2. Product Portfolio
    • 21.3.4.3. Key Financials
    • 21.3.4.4. SWOT Analysis
    • 21.3.4.5. Sales Footprint
    • 21.3.4.6. Key Developments
    • 21.3.4.7. Strategy Overview
  • 21.3.5. Sanofi S.A.
    • 21.3.5.1. Overview
    • 21.3.5.2. Product Portfolio
    • 21.3.5.3. Key Financials
    • 21.3.5.4. SWOT Analysis
    • 21.3.5.5. Sales Footprint
    • 21.3.5.6. Key Developments
    • 21.3.5.7. Strategy Overview
  • 21.3.6. Hisamitsu Pharmaceutical Co., Inc.
    • 21.3.6.1. Overview
    • 21.3.6.2. Product Portfolio
    • 21.3.6.3. Key Financials
    • 21.3.6.4. SWOT Analysis
    • 21.3.6.5. Sales Footprint
    • 21.3.6.6. Key Developments
    • 21.3.6.7. Strategy Overview
  • 21.3.7. GlaxoSmithKline Plc.
    • 21.3.7.1. Overview
    • 21.3.7.2. Product Portfolio
    • 21.3.7.3. Key Financials
    • 21.3.7.4. SWOT Analysis
    • 21.3.7.5. Sales Footprint
    • 21.3.7.6. Key Developments
    • 21.3.7.7. Strategy Overview
  • 21.3.8. Novartis AG
    • 21.3.8.1. Overview
    • 21.3.8.2. Product Portfolio
    • 21.3.8.3. Key Financials
    • 21.3.8.4. SWOT Analysis
    • 21.3.8.5. Sales Footprint
    • 21.3.8.6. Key Developments
    • 21.3.8.7. Strategy Overview
  • 21.3.9. Nichiban Co., Ltd.
    • 21.3.9.1. Overview
    • 21.3.9.2. Product Portfolio
    • 21.3.9.3. Key Financials
    • 21.3.9.4. SWOT Analysis
    • 21.3.9.5. Sales Footprint
    • 21.3.9.6. Key Developments
    • 21.3.9.7. Strategy Overview
  • 21.3.10. Teikoku Seiyaku Co, Ltd.
    • 21.3.10.1. Overview
    • 21.3.10.2. Product Portfolio
    • 21.3.10.3. Key Financials
    • 21.3.10.4. SWOT Analysis
    • 21.3.10.5. Sales Footprint
    • 21.3.10.6. Key Developments
    • 21.3.10.7. Strategy Overview
  • 21.3.11. Mentholatum Company.
    • 21.3.11.1. Overview
    • 21.3.11.2. Product Portfolio
    • 21.3.11.3. Key Financials
    • 21.3.11.4. SWOT Analysis
    • 21.3.11.5. Sales Footprint
    • 21.3.11.6. Key Developments
    • 21.3.11.7. Strategy Overview
  • 21.3.12. Purdue Pharma L.P.
    • 21.3.12.1. Overview
    • 21.3.12.2. Product Portfolio
    • 21.3.12.3. Key Financials
    • 21.3.12.4. SWOT Analysis
    • 21.3.12.5. Sales Footprint
    • 21.3.12.6. Key Developments
    • 21.3.12.7. Strategy Overview
  • 21.3.13. West-Ward Pharmaceuticals Corporation
    • 21.3.13.1. Overview
    • 21.3.13.2. Product Portfolio
    • 21.3.13.3. Key Financials
    • 21.3.13.4. SWOT Analysis
    • 21.3.13.5. Sales Footprint
    • 21.3.13.6. Key Developments
    • 21.3.13.7. Strategy Overview
  • 21.3.14. Pfizer, Inc
    • 21.3.14.1. Overview
    • 21.3.14.2. Product Portfolio
    • 21.3.14.3. Key Financials
    • 21.3.14.4. SWOT Analysis
    • 21.3.14.5. Sales Footprint
    • 21.3.14.6. Key Developments
    • 21.3.14.7. Strategy Overview
  • 21.3.15. Allergan Plc (Actavis)
    • 21.3.15.1. Overview
    • 21.3.15.2. Product Portfolio
    • 21.3.15.3. Key Financials
    • 21.3.15.4. SWOT Analysis
    • 21.3.15.5. Sales Footprint
    • 21.3.15.6. Key Developments
    • 21.3.15.7. Strategy Overview
  • 21.3.16. Endo International plc,
    • 21.3.16.1. Overview
    • 21.3.16.2. Product Portfolio
    • 21.3.16.3. Key Financials
    • 21.3.16.4. SWOT Analysis
    • 21.3.16.5. Sales Footprint
    • 21.3.16.6. Key Developments
    • 21.3.16.7. Strategy Overview
  • 21.3.17. Mylan N.V.
    • 21.3.17.1. Overview
    • 21.3.17.2. Product Portfolio
    • 21.3.17.3. Key Financials
    • 21.3.17.4. SWOT Analysis
    • 21.3.17.5. Sales Footprint
    • 21.3.17.6. Key Developments
    • 21.3.17.7. Strategy Overview

22. Assumptions and Acronyms Used

23. Research Methodology

관련자료